Earnings Call · Q2 FY2021·2021-08-11

Q2 21EPS -13.21%·Rev n/aQ1 21EPS +48.65%·Rev n/aQ4 20EPS +78.75%·Rev n/aQ3 20EPS +28.95%·Rev n/a⚠ consensus missing

Altimmune, Inc. ALT

Will Brown — Chief Financial Officer

Vipin Garg — Chief Executive Officer

Scott Harris — Chief Medical Officer

Scot Roberts — Chief Scientific Officer

+2.5%1d on move date+2.2% vs SPY3d+10.5%5d+10.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALT calls or request research access.

More ALT calls Browse calls Request research access